Understand complex
biology through agentic AI

Transforming research with agentic reasoning to create biological artificial superintelligence
Biology is profoundly complex

Countless interactions across cells, tissues, and networks generate huge complexity. Untangling this complexity is beyond the limits of human intelligence alone.

Agentic AI is the answer

Owkin is pioneering advanced agentic AI that can process vast biological data, uncover hidden causal relationships, and generate new actionable insights.

Powered by unique patient data

We generate and access rich multimodal patient data and biological samples across diverse populations from top academic research institutions.

Discover our data network
One software

Owkin K is an agentic AI platform driving insight generation and decision making across teams to accelerate breakthroughs and advance drug discovery, development, and diagnostics.

Learn more

Countless interactions across cells, tissues, and networks generate huge complexity. Untangling this complexity is beyond the limits of human intelligence alone.

Owkin is pioneering advanced agentic AI that can process vast biological data, uncover hidden causal relationships, and generate new actionable insights.

We generate and access rich multimodal patient data and biological samples across diverse populations from top academic research institutions.

Discover our data network

Owkin K is an agentic AI platform driving insight generation and decision making across teams to accelerate breakthroughs and advance drug discovery, development, and diagnostics.

Learn more
At Owkin, we're not just pushing the boundaries of AI in life sciences; we're building the tools and intelligence to change how medicine is discovered, developed, and delivered to patients.
K Navigator screen

An agentic playground for researchers to explore and validate biological hypotheses using literature, knowledge frameworks, and multimodal data (including spatial omics).

Try for free
K Pro screen

An agentic AI platform powered by a suite of intelligent agents and cutting-edge multimodal data, designed to generate instant insights, and support decision-making.

Launching soon

One company: many breakthroughs

At Owkin, we’ve designed a structure that maximizes both focus and collaboration. Our group of specialized companies work seamlessly together, combining deep expertise with a shared mission to accelerate biological discovery.
Owkin Core (Owkin K)

The technology foundation of our ecosystem is Owkin K. It is our cutting edge software that incorporates high quality multimodal data and AI tools to power breakthroughs across our companies.

Epkin

Developer of OKN4395, a first-in-class selective triple inhibitor of EP2, EP4, and DP1. Currently in phase 1 (INVOKE), it is the first Owkin program to fully leverage AI, from asset selection to clinical development.

Owkin Dx

A leader in clinically validated digital pathology AI diagnostics. Solutions to support pathologists, screen biomarkers, and predict patient outcomes. The product portfolio spans tools for clinical trials, and regulatory-approved IVD solutions for routine clinical use.

Bioptimus

Incubated by Owkin
Bioptimus is building the first universal reference AI foundation model in biology to drive advancements in scientific research and biotechnological innovation.

What makes our technology different?

Our AI is differentiated by top quality patient data, quantification technologies and cutting edge agentic applications:

Unparallelled access to multimodal data

  • World-class, AI-ready, multimodal patient data ingested and harmonized from a network of leading academic partners
  • Research-grade, multimodal patient data to capture the full heterogeneity of disease
  • Cutting-edge new modalities such as single-cell and spatial omics via MOSAIC
Find out more
Button
Data
Cutting-edge AI to quantify biology
  • Multiscale AI embeddings to connect dots across cellular, molecular, and tissue scales and patients, drugs, and diseases to map a common representation of biology
  • Owkin K combines reinforcement learning, fine-tuned LLMs, and multimodal foundation models
  • Interpretable predictive models validated by medical experts
Find out more
Button
Biological quantification
Pioneering agentic AI
  • AI agents to transform actionable biomarkers into pipeline value for pharma
  • Powered by multimodal, causal, interpretable AI to build robust patient outcome models
  • Integrates automated lab perturbation with clinical patient response data to ensure that biological insights evolve instantly based on real-world validation
Find out more
Button
Agentic AI

What's new at Owkin?

Explore our site
Blog
Electric energy and emerging AI

What we brought to and learned from ASCO 2025

June 11, 2025
Button
Exhibition
AI in Oncology by IHU Prism

The combination of AI, digital pathology, and molecular analysis is creating a new paradigm in cancer diagnostics. Learn how Owkin is leveraging these technologies to enable more personalized and effective treatment strategies.

June 17, 2025
Button
Case study
Case study: TLS Detect

Prediction of patient’s TLS status from H&E whole slide images in pan-cancer cohort

Play

We are hiring

Join our team

We are a community of diverse people bringing our energy and skills to find the right treatment for every patient.

Careers at Owkin